Sign In
Buy KALV
KalVista Pharmaceuticals Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be negative at -42.42. In total, the insiders bought 1.17M and sold 342.12K KALV shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
-42.42 |
| ● Buy | 1.17M shares |
| ● Sell | 342.12K shares |
|
67% Buy Activity
Negligible or No Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
May 21, 2026 Buy |
Palleiko Benjamin L Chief Executive Officer |
23 250 Value: $622.4K |
||
|
May 21, 2026 Buy |
Yea Christopher Chief Development Officer |
3 750 Value: $100.4K |
||
|
May 18, 2026 Sell |
Yea Christopher Chief Development Officer |
1 108 Value: $29.7K |
||
|
May 18, 2026 Sell |
Palleiko Benjamin L Chief Executive Officer |
1 129 Value: $30.2K |
||
|
May 18, 2026 Sell |
Audhya Paul K. Chief Medical Officer |
1 032 Value: $27.6K |
||
|
May 17, 2026 Buy |
Yea Christopher Chief Development Officer |
1 774 Value: $47.8K |
||
|
May 17, 2026 Buy |
Palleiko Benjamin L Chief Executive Officer |
2 419 Value: $65.2K |
||
|
May 17, 2026 Buy |
Palleiko Benjamin L Chief Executive Officer |
2 419 Value: $65.2K |
||
|
May 17, 2026 Buy |
Audhya Paul K. Chief Medical Officer |
2 419 Value: $65.2K |
||
|
May 17, 2026 Buy |
Audhya Paul K. Chief Medical Officer |
2 419 Value: $65.2K |
||
|
May 17, 2026 Buy |
Yea Christopher Chief Development Officer |
1 774 Value: $47.8K |
||
|
May 12, 2026 Sell |
Palleiko Benjamin L Chief Executive Officer |
3 322 Value: $88.7K |
||
|
May 11, 2026 Buy |
Palleiko Benjamin L Chief Executive Officer |
7 120 Value: $190.2K |
||
|
May 11, 2026 Buy |
Palleiko Benjamin L Chief Executive Officer |
7 120 Value: $190.2K |
||
|
Apr 17, 2026 Sell |
Piekos Brian Chief Financial Officer |
1 862 Value: $37.6K |
||
|
Apr 17, 2026 Sell |
Sweeny Nicole Chief Commercial Officer |
1 862 Value: $37.6K |
||
|
Apr 17, 2026 Sell |
Audhya Paul K. Chief Medical Officer |
2 686 Value: $54.3K |
||
|
Apr 17, 2026 Sell |
Palleiko Benjamin L Chief Executive Officer |
9 550 Value: $193.1K |
||
|
Apr 16, 2026 Buy |
Palleiko Benjamin L Chief Executive Officer |
20 312 Value: $397.3K |
||
|
Apr 16, 2026 Buy |
Piekos Brian Chief Financial Officer |
6 250 Value: $122.3K |
||
|
Apr 16, 2026 Buy |
Piekos Brian Chief Financial Officer |
6 250 Value: $122.3K |
||
|
Apr 16, 2026 Buy |
Sweeny Nicole Chief Commercial Officer |
6 250 Value: $122.3K |
||
|
Apr 16, 2026 Buy |
Sweeny Nicole Chief Commercial Officer |
6 250 Value: $122.3K |
||
|
Apr 16, 2026 Buy |
Audhya Paul K. Chief Medical Officer |
6 250 Value: $122.3K |
||
|
Apr 16, 2026 Buy |
Audhya Paul K. Chief Medical Officer |
6 250 Value: $122.3K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
